138 related articles for article (PubMed ID: 17223901)
21. Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab.
Iqbal M; Kolodney MS
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S118-20. PubMed ID: 15858507
[TBL] [Abstract][Full Text] [Related]
22. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
[TBL] [Abstract][Full Text] [Related]
23. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
Dauendorffer JN; Rivet J; Allard A; Bachelez H
Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820
[TBL] [Abstract][Full Text] [Related]
24. Infliximab in a patient with refractory mucosal aphthosis.
Jacobi A; Debus D; Schuler G; Hertl M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):109-10. PubMed ID: 18181985
[No Abstract] [Full Text] [Related]
25. Infliximab-induced acne and acute localized exanthematous pustulosis: Case report.
Senilă S; Seicean A; Fechete O; Grad A; Ungureanu L
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28976720
[No Abstract] [Full Text] [Related]
26. Erythema nodosum associated with infliximab therapy.
Rosen T; Martinelli P
Dermatol Online J; 2008 Apr; 14(4):3. PubMed ID: 18627725
[TBL] [Abstract][Full Text] [Related]
27. Transient type III atrioventricular block after infliximab infusion in a fistulizing perianal Crohn's disease patient.
Sofos S; Savoye G; Ramirez S; Bauer F; Lerebours E
Am J Gastroenterol; 2007 Jan; 102(1):217-9. PubMed ID: 17278277
[No Abstract] [Full Text] [Related]
28. Does administration of infliximab increase susceptibility to listeriosis?
Morelli J; Wilson FA
Am J Gastroenterol; 2000 Mar; 95(3):841-2. PubMed ID: 10710107
[No Abstract] [Full Text] [Related]
29. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area.
Jain VV; Evans T; Peterson MW
Respir Med; 2006 Jul; 100(7):1291-3. PubMed ID: 16545951
[TBL] [Abstract][Full Text] [Related]
30. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
[TBL] [Abstract][Full Text] [Related]
31. Infliximab-induced lichen planopilaris.
Fernández-Torres R; Paradela S; Valbuena L; Fonseca E
Ann Pharmacother; 2010 Sep; 44(9):1501-3. PubMed ID: 20702759
[TBL] [Abstract][Full Text] [Related]
32. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
Peyrin-Biroulet L; Bressenot A; Chone L; Denjean P; Boissel P; Bigard MA; Bronowicki JP
Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
[No Abstract] [Full Text] [Related]
33. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
[TBL] [Abstract][Full Text] [Related]
34. Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-alpha antibody.
Kohara MM; Blum RN
Clin Infect Dis; 2006 Mar; 42(5):733-4. PubMed ID: 16447129
[No Abstract] [Full Text] [Related]
35. [Legionella pneumonia in patients treated with infliximab].
Vinter H; Nielsen HI
Ugeskr Laeger; 2009 Jan; 171(4):247. PubMed ID: 19174042
[TBL] [Abstract][Full Text] [Related]
36. Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis.
Newell EL; Jain S; Stephens C; Martland G
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):230-1. PubMed ID: 18680531
[No Abstract] [Full Text] [Related]
37. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
Moss AC; Treister NS; Marsee DK; Cheifetz AS
Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
[No Abstract] [Full Text] [Related]
38. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis.
Garcia Vidal C; Rodríguez Fernández S; Martínez Lacasa J; Salavert M; Vidal R; Rodríguez Carballeira M; Garau J
Clin Infect Dis; 2005 Mar; 40(5):756-9. PubMed ID: 15714425
[TBL] [Abstract][Full Text] [Related]
39. Unusual presentation of tuberculosis after infliximab therapy.
Magro F; Pereira P; Veloso FT; Carneiro F
Inflamm Bowel Dis; 2005 Jan; 11(1):82-4. PubMed ID: 15674123
[No Abstract] [Full Text] [Related]
40. Crohn's disease, infliximab and idiopathic thrombocytopenic purpura.
Selby LA; Hess D; Shashidar H; de Villiers WJ; Selby LA
Inflamm Bowel Dis; 2004 Sep; 10(5):698-700. PubMed ID: 15472539
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
